432 related articles for article (PubMed ID: 16508892)
1. Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia.
Gründer G; Kungel M; Ebrecht M; Göröcs T; Modell S
Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S21-5. PubMed ID: 16508892
[TBL] [Abstract][Full Text] [Related]
2. Persistent hiccups associated with switching from risperidone to aripiprazole in a schizophrenic patient with cerebral palsy.
Yeh YW
Clin Neuropharmacol; 2011; 34(4):135-6. PubMed ID: 21768798
[TBL] [Abstract][Full Text] [Related]
3. Aripiprazole as a dopamine partial agonist: positive and negative effects.
Glick ID; Duggal V; Hodulik C
J Clin Psychopharmacol; 2006 Feb; 26(1):101-3. PubMed ID: 16415723
[No Abstract] [Full Text] [Related]
4. Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic.
Keck PE; McElroy SL
Expert Opin Investig Drugs; 2003 Apr; 12(4):655-62. PubMed ID: 12665420
[TBL] [Abstract][Full Text] [Related]
5. [A new approach to antischizophrenic therapeutics: D2 dopamine receptor partial agonists].
Costentin J
Ann Pharm Fr; 2009 Sep; 67(5):310-9. PubMed ID: 19695367
[TBL] [Abstract][Full Text] [Related]
6. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
[TBL] [Abstract][Full Text] [Related]
7. [Aripiprazole in the treatment of schizophrenia].
Bridler R
Praxis (Bern 1994); 2005 Jun; 94(23):975-7. PubMed ID: 16001540
[No Abstract] [Full Text] [Related]
8. [A new pharmacological strategy for schizophrenia: the partial agonists of D2 dopaminergic receptors. The principle characteristics of aripiprazole].
Costentin J
Encephale; 2009 Feb; 35(1):66-72. PubMed ID: 19250996
[TBL] [Abstract][Full Text] [Related]
9. Do dopamine partial agonists have partial efficacy as antipsychotics?
Stahl SM
CNS Spectr; 2008 Apr; 13(4):279-82. PubMed ID: 18408646
[No Abstract] [Full Text] [Related]
10. Partial agonists in schizophrenia--why some work and others do not: insights from preclinical animal models.
Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S
Int J Neuropsychopharmacol; 2011 Oct; 14(9):1165-78. PubMed ID: 21087552
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole: what is the role of dopamine D(2) receptor partial agonism?
Kessler RM
Am J Psychiatry; 2007 Sep; 164(9):1310-2. PubMed ID: 17728411
[No Abstract] [Full Text] [Related]
12. Aripiprazole: does partial dopaminergic agonism translate into clinical benefits?
Crismon ML; DeLeon A; Miller AL
Ann Pharmacother; 2003 May; 37(5):738-40. PubMed ID: 12708954
[No Abstract] [Full Text] [Related]
13. [A new atypical antipsychotic with partial dopamine agonist effect (aripiprazole)].
Kerpel-Fronius S; Lóránt M
Neuropsychopharmacol Hung; 2004 Dec; 6(4):177-84. PubMed ID: 15825673
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole in the treatment of Alzheimer's disease.
De Deyn PP; Drenth AF; Kremer BP; Oude Voshaar RC; Van Dam D
Expert Opin Pharmacother; 2013 Mar; 14(4):459-74. PubMed ID: 23350964
[TBL] [Abstract][Full Text] [Related]
15. A review of the safety and tolerability of aripiprazole.
Pae CU
Expert Opin Drug Saf; 2009 May; 8(3):373-86. PubMed ID: 19505266
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.
Mamo D; Graff A; Mizrahi R; Shammi CM; Romeyer F; Kapur S
Am J Psychiatry; 2007 Sep; 164(9):1411-7. PubMed ID: 17728427
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacology of antipsychotics at human dopamine D2 and D3 receptors].
Tadori Y; Kikuchi T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Feb; 32(1):9-18. PubMed ID: 22568121
[TBL] [Abstract][Full Text] [Related]
18. Aripiprazole treatment causes extrapyramidal side effects but not prolactin elevation: a disconnect of the striatal D2 occupancy story: case report.
Shim JC; You YS; Kelly DL
J Clin Psychopharmacol; 2008 Jun; 28(3):353-4. PubMed ID: 18480699
[No Abstract] [Full Text] [Related]
19. Mechanism of action of brexpiprazole: comparison with aripiprazole.
Stahl SM
CNS Spectr; 2016 Feb; 21(1):1-6. PubMed ID: 26899451
[TBL] [Abstract][Full Text] [Related]
20. Partial dopamine agonists in schizophrenia.
Launer M
Hosp Med; 2005 May; 66(5):300-3. PubMed ID: 15920862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]